"Melita Medical to połączenie najnowocześniejszych metod leczenia oraz diagnostyki z przyjazną i profesjonalną opieką. Najważniejsze są dla nas poczucie bezpieczeństwa i komfortu naszych pacjentów. Obszary, w których oferujemy pomoc to proktologia, gastroenterologia, hepatologia, onkologia, hematologia oraz pulmonologia. Zajmujemy się prowadzeniem badań klinicznych dotyczących takich chorób jak wrzodziejące zapalenie jelita grubego, choroba Crohna i zapalenie jelita grubego wywołane infekcją Clostridium difficile. Centrum Medyczne Wrocław Melita Medical to zespół lekarzy z Polski oraz Malty, których łączy wspólny cel - dostarczanie pacjentom kompleksowej opieki. Zapraszamy do kontaktu."

During the past decade, Melita Medical Sp. Z O. O. conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 12 clinical trials were completed, i.e. on average, 41.4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 11 clinical trials were completed. i.e. 68.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Melita Medical Sp. Z O. O." #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Pfizer" with 5 trials sponsored, "Shire" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Genentech, Inc." with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Melita Medical Sp. Z O. O." #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Melita Medical Sp. Z O. O." are "Crohn's Disease" (12 trials), "Ulcerative Colitis" (9 trials), "Colitis, Ulcerative" (3 trials), "Cancer of the Prostate" (2 trials) and "Crohn Disease" (2 trials). Many other conditions were trialed in "Melita Medical Sp. Z O. O." in a lesser frequency.

Most popular intervention types in "Melita Medical Sp. Z O. O." are "Drug" (26 trials), "Other" (8 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Guselkumab" (4 trials), "Guselkumab Dose 1" (4 trials), "Guselkumab Dose 2" (4 trials) and "Ontamalimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Melita Medical Sp. Z O. O." are 28 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Melita Medical Sp. Z O. O.". undefined are not yet recruiting, 6 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Melita Medical Sp. Z O. O., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Melita Medical Sp. Z O. O., 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".